Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2015 16:15 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2015 Results

SCHAUMBURG, Ill., April 27, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
April 16, 2015 07:30 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Appoints Michael Logerfo as President

SCHAUMBURG, Ill., April 16, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
April 16, 2015 07:30 ET | Source: Sagent Pharmaceuticals, Inc.

Shlomo Yanai Joins Sagent Pharmaceuticals Board of Directors

SCHAUMBURG, Ill., April 16, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
April 13, 2015 06:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride for Injection, USP

SCHAUMBURG, Ill., April 13, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 10...
March 26, 2015 07:30 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces Leadership Changes

--Jeffrey Yordon Retires as Chairman and CEO; Board Member, Frank Kung, Ph.D. Appointed Chairman-- --Board Launches Search for Permanent CEO-- --Company Reiterates its Guidance Range for...
February 23, 2015 11:18 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Atracurium Besylate Injection, USP, 50mg/5mL and 100mg/10mL Due to FDA Observations Pertaining to Aseptic and GMP Practices at the Manufacturer's Site Potentially Impacting Product Sterility

SCHAUMBURG, Ill., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose...
February 19, 2015 07:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Results

Record quarterly revenue primarily driven by new product launches and Oct. 1 addition of Omega Laboratories Full year results exceed updated Fiscal Year 2014 earnings guidance SCHAUMBURG,...
February 12, 2015 08:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Sets Date and Time for Release of Fourth Quarter and Full Year 2014 Financial Results

SCHAUMBURG, Ill., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
January 08, 2015 16:29 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals to Present at 33rd Annual J.P. Morgan Healthcare Conference

SCHAUMBURG, Ill., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
December 30, 2014 08:30 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Launch of Colistimethate for Injection, USP

SCHAUMBURG, Ill., Dec. 30, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Colistimethate for Injection, USP, an anti-infective, in a...